Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica

Multiple Sclerosis Journal

Volumn 19, Issue 3, 2013, Pages 308-315

  Makino, Takahiro ^a   Ito, Shoichi ^a   Mori, Masahiro ^a   Yonezu, Tadahiro ^a   Ogawa, Yoshitsugu ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

corpus callosum; demyelinating disease; magnetic resonance imaging; multiple sclerosis; Neuromyelitis optica

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; CALLOSAL LESION; CLINICAL ARTICLE; CORPUS CALLOSUM; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 84867776316     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512454772     Document Type: Article

References (33)

1. Wingerchuk DM. Neuromyelitis optica: new findings on pathogenesis. Int Rev Neurobiol. 2007 ; 79: 665-688
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112
3. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 ; 202: 473-477
4. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008 ; 196: 181-187
5. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007 ; 130: 1235-1243
6. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci. 2003 ; 4: 991-1001
7. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, et al. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997 ; 17: 171-180
8. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009 ; 66: 630-643
9. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 ; 63: 390-396
10. Ito S, Mori M, Makino T, et al. 'Cloud-like enhancement' is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009 ; 66: 425-428
11. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996 ; 60: 382-387
12. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 ; 63: 964-968
13. Nakamura M, Misu T, Fujihara K, et al. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler. 2009 ; 15: 695-700
14. Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology. 1991 ; 180: 215-221
15. Simon JH, Holtås SL, Schiffer RB, et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. Radiology. 1986 ; 160: 363-367
16. Friese SA, Bitzer M, Freudenstein D, et al. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology. 2000 ; 42: 795-802
17. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
18. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846
19. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 ; 120: 2059-2069
20. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain. 2007 ; 130: 1206-1223
21. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology. 1995 ; 195: 725-732
22. Aboitiz F, López J, Montiel J. Long distance communication in the human brain: timing constraints for inter-hemispheric synchrony and the origin of brain lateralization. Biol Res. 2003 ; 36: 89-99
23. Hofer S, Frahm J. Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. NeuroImage. 2006 ; 32: 989-994
24. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007 ; 130: 1224-1234
25. Vincent T, Saikali P, Cayrol R, et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol. 2008 ; 181: 5730-5737
26. Matsushita T, Isobe N, Matsuoka T, et al. Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler. 2009 ; 15: 1113-1117
27. Prineas WP, McDonald WI Greenfield's neuropathology. 6 th ed.New York: Oxford University Press; 1997: pp. 815-868. Graham DI Lantos PL, ed. New York: Oxford University Press ; 1997: 815-868.
28. Adams CW, Abdulla YH, Torres EM, et al. Periventricular lesions in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neuropathol Appl Neurobiol. 1987 ; 13: 141-152
29. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 ; 125: 1450-1461
30. Nakamura M, Endo M, Murakami K, et al. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler. 2005 ; 11: 735-738
31. Uzawa A, Mori M, Hayakawa S, et al. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol. 2010 ; 17: 672-676
32. Papeix C, Vidal JS, De Seze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007 ; 13: 256-259
33. Watanabe S, Misu T, Miyazawa I, et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler. 2007 ; 13: 968-974